English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

We commend Kądziela et al. [1] for their excellent study entitled “Prognostic value of renal fractional flow reserve in blood pressure response after renal artery stenting (PREFER study)” evaluating a potential relationship between resting translesional pressures ratio (Pd/Pa ratio), renal fractional flow reserve (rFFR) and blood pressure response after renal stenting. They concluded that physiological assessment of renal artery stenosis using Pd/Pa ratio and rFFR did not predict hypertension response after stenting [1]. However, we have several concerns about the true value of rFFR. First, in a study by Mitchell et al. [2], rFFR was measured in 17 subjects with refractory hypertension and renal artery stenosis at 3 months after stent. 86% of the patients with abnormal rFFR experienced improvement, compared to only 30% of those with normal rFFR (p = 0.04). In another study carried by Leesar et al. [3], using rFFR to predict hypertension improvement after stenting, the area under receiver operating characteristic curve was 0.85 (95% CI 0.76–0.94, sensitivity 73%, specificity 88%, predictive accuracy 79%). Besides, the odds ratio of rFFR was 0.79 (95% CI 0.69–0.90, p = 0.0007) by univariate predictors at 12 months after stenting. Therefore, we could draw an opposite conclusion from the PREFER study that rFFR was a promising tool to identify patients likely to benefit from renal stent. Second, the PREFER study designed the subgroups by Pd/Pa ratio (cut-point = 0.9) and rFFR (cut-point = 0.8) [1]. However, Leesar et al. [3] have once employed the cut-point of rFFR = 0.90 in predicting hypertension improvement after stenting, and Kądziela et al. [4] recommended the best accuracy point for Pd/Pa ratio as 0.93. Therefore, the threshold value should be further discussed considering the poor predictive value of rFFR. Besides, Mangiacapra et al. [5] validated that translesional systolic pressure gradient (TSPG) ≥ 20 mm Hg was highly predictive of hypertension improvement after renal stenting and useful for appropriate selection of stenting patients. In the PREFER study, the diagnostic value of TSPG to predict hypertension response should be further analyzed in addition to a strong correlation with Pd/Pa ratio (r = –0.89, p < 0.001) and rFFR (r = –0.86, p < 0.0001) [1], which could convince the uselessness of rFFR for predicting hypertension improvement. Finally, only 35 hypertensive patients were enrolled and underwent renal stenting, although the recruitment was challenging [1]. The major concerns included the invasiveness and potential risk of extra procedure of pressure-wire across the stenosis. The limited size certainly reduced the reliability of rFFR in hypertension response. We noticed that all subjects underwent 64-detector computed tomography (CT) angiography examinations before the stent and after 6 months. Recently, noninvasive quantification of FFR by computational fluid dynamics applied to CT angiography has been validated by multicenter DISCOVER-FLOW study and DeFACTO trial [6]. Moreover, both studies suggested that the novel technology was also applicable to other common cardiovascular conditions and might be used to determine whether renal artery stenosis was significant [6]. Therefore, noninvasive rFFR will be a potential predictive tool and markedly promote the large size clinical trials of renal artery stent.

Renal fractional flow reserve: Is it available to predict hypertension improvement after stenting?